Bio-Rad Laboratories | BIO - Vermögenswerte





Vermögenswerte Veränderung Datum
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 12.81B 86M 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Bio Techne USD 2.52B 3.45M 2025-12
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
Bruker USD 6.24B 193.5M 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Danaher USD 83.54B 80M 2026-03
General Electric Aerospace USD 128.45B 1.72B 2026-03
Illumina USD 6.64B 467M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Merck USD 136.87B 7.32B 2025-12
Mettler Toledo International USD 3.71B 191.18M 2025-12
Myriad Genetics USD 706.6M 21.5M 2025-12
OraSure Technologies USD 403.17M 19.93M 2025-12
Pacific Biosciences Of California USD 784.08M 19.08M 2025-12
Quest Diagnostics USD 16.67B 448M 2026-03
Repligen USD 2.95B 25.99M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Siemens EUR 170.13B 3.93B 2025-12
Standard Biotools USD 567.75M 28.12M 2025-12
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Tosoh JPY 1.34T 44.3B 2025-12
Waters USD 5.08B 221.41M 2025-12